{
    "Trade/Device Name(s)": [
        "N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Products GmbH",
    "510(k) Number": "K233663",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083445"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFN"
    ],
    "Summary Letter Date": "December 13, 2023",
    "Summary Letter Received Date": "November 15, 2023",
    "Submission Date": "November 15, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Immunoglobulin G",
        "Immunoglobulin A",
        "Immunoglobulin M"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma",
        "EDTA plasma",
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BN II System",
        "BN ProSpec System"
    ],
    "Method(s)/Technology(ies)": [
        "Immunonephelometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens N Antisera to Human Immunoglobulins (IgG, IgA, and IgM) in serum, plasma, urine, and CSF by immunonephelometry with added High Dose Hook claim for CSF samples.",
    "Indications for Use Summary": "In-vitro diagnostic reagents for quantitative determination of immunoglobulins (IgG, IgA, IgM) in human serum, heparinized and EDTA plasma, and IgG in urine and CSF by immunonephelometry on BN II and BN ProSpec systems; IgG measurement aids in diagnosing abnormal protein metabolism and immune deficiencies.",
    "fda_folder": "Immunology"
}